-
Cognitive Symptom Score From EHR Predicts Risk for Dementia
drugs
December 23, 2019
A cognitive symptom measure identified in discharge summaries can predict the risk for dementia, according to a study published online in Alzheimer's & Dementia.
-
Ionis Licenses Investigational Alzheimer's Therapy
americanpharmaceuticalreview
December 23, 2019
Ionis Pharmaceuticals announced Biogen, a collaboration partner for neurological diseases, has licensed IONIS-MAPTRx, an antisense therapy designed to selectively reduce production ...
-
Alkahest Presents Alzheimer’s Disease Study Data
americanpharmaceuticalreview
December 16, 2019
Alkahest presented data from its phase 2a study, AKST6019-201, in mild-to-moderate Alzheimer’s Disease (AD).
-
Shanghai Green Valley’s Class 1 New Drug for Alzheimer’s Disease Conditionally Approved for Marketing and Already Having the Registration Approval!
PharmaSources/Caicai
November 14, 2019
The National Medical Products Administration of China (NMPA) released on its website yesterday (Nov. 2, 2019) some big news that shocks the industry.
-
BioMed X Completes Alzheimer’s Disease Research Project
b3cnewswire
October 29, 2019
BioMed X announced the successful completion of their first research collaboration project with AbbVie in the field of tau-mediated neurodegeneration in Alzheimer’s disease.
-
Yo-Yoing Blood Pressure Could Be Bad for Those With Alzheimer's
drugs
September 24, 2019
Fluctuating blood pressure may be associated with worsening dementia in people with Alzheimer's disease, according to new research.
-
For People at High Risk, Evidence That Exercise Might Slow Alzheimer's
drugs
September 20, 2019
For people at risk of Alzheimer's disease, working out a couple of times a week might at least slow the onset of the illness, according to a new study published Sept. 17 in the Journal of Alzheimer's Disease.
-
QPS Expands Global Footprint
contractpharma
September 20, 2019
QPS, a CRO, has expanded its global footprint with new clinics in the Netherlands and India. QPS Netherlands recently opening a second clinic ...
-
Migraines Linked to Higher Risk for Dementia, Alzheimer Disease
drugs
September 19, 2019
Migraines are a significant risk factor for Alzheimer disease (AD) and all-cause dementia.Rebecca E. Morton, from University of Waterloo in Canada, and colleagues used data from ...
-
New drug may protect against memory loss in Alzheimer's disease
worldpharmanews
September 10, 2019
A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics may protect against memory loss...